| PD-L1 | Programmed death-ligand 1 |
| PD-1 | Programmed cell death-1 |
| VEGF | Vascular endothelial growth factor |
| VEGFR | VEGF receptor |
| EGFR | Epidermal growth factor receptor |
| TKIs | Tyrosine kinase inhibitors |
| ICIs | Immune checkpoint inhibitors |
| TME | Tumor microenvironment |
| TMB | Tumor mutational burden |
| IHC | Immunohistochemistry |
| FCM | Flow cytometry |
| NK | Natural killer |
| NSCLCs | Non-small cell lung cancers |
| Tregs | Regulatory T-cells |
| CTL | Cytotoxic T lymphocytes |
| TILs | Tumor-infiltrating lymphocytes |
| Chemo-IO | Chemotherapy plus ICI |
| GEMM | Genetically engineered mouse model |
| PBS | Phosphate-buffered saline |
| RNA-seq | RNA-sequencing |
| TPM | Transcripts per million |
| RPK | Reads per kilobase |
| mMCP | Murine Microenvironment Cell Population |
| NCR1 | Natural cytotoxicity triggering receptor 1 |
| αSMA | Alpha smooth muscle actin |